Table 1.
Clinicopathological features | |
Patients | n = 77 |
Gender | male : female = 38 : 10 |
Age (yr) | mean = 66.6 (44-85) |
Virus infection | HCV : HBV : NBNC = 72 : 4 : 1 |
UICC-TNM classification | I : II : IIIA : IIIB = 41 : 32 : 3 : 1 |
Tumor number | single : multiple : unknown = 48 : 28 : 1 |
Tumor size (cm) | mean = 3.0 (1.0-9.5) |
Portal vein invasion | yes : no : unknown = 7 : 68 : 2 |
Tumor differentiation | well : mod : poor : unknown = 18 : 44 : 13 : 2 |
Number of platelet (× 104) | mean = 13.4 (3.8-28.1) |
Alanine aminotransferase (ALT) (U/L) | mean = 50.9 (16-207) |
Total bilirubin (mg/dL) | mean = 0.9 (0.3-1.9) |
Prothrombin activity (%) | mean = 77.1 (33.0-104.0) |
Indocyanine green R15 (%) | mean = 19.1 (6.0-44.4) |
Alpha-fetoprotein (ng/mL) | mean = 389.6 (1.8-602.6) |
From July 2000 to June 2008, consecutive patients in the University of Yamanashi Hospital (Yamanashi, Japan) who (1) were diagnosed as having HCC and (2) underwent curative resection surgery, were enrolled in this study.